AstraZeneca plc (ADR)
NYSE: AZN
$44.66
+$0.13 (+0.3%)
Closing price March 31, 2020
Until late Monday, Amarin continued to get good news relevant to Vascepa, its treatment for cardiovascular disease. The big news, though, was lurking in Nevada federal district court.
12 hours ago
Some investors are looking for conservative growth ideas, and big pharma may be the ticket. These four top stocks have been hit hard, and the companies have paid dependable dividends for years.
19 hours ago
24/7 Wall St. screened the Merrill Lynch health care research database looking for large pharmaceutical leaders that also pay solid and dependable dividends. These five make sense for growth and...
1 month ago
Last Updated: 1 month ago
When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout or an extremely positive change in a company's future prospects. For Genprex, it was a nod from...
2 months ago
AstraZeneca has announced that the FDA has approved its companion diagnostic test that identifies patients with metastatic pancreatic cancer.
3 months ago
Last Updated: 2 months ago
The top analyst upgrades, downgrades and initiations for Wednesday included Acorda Therapeutics, Activision Blizzard, Bloom Energy, Care.com, CBS, Deere and Ferrari.
7 months ago
Last Updated: 2 months ago
Inovio Pharmaceuticals shares dipped on Wednesday after it was announced that the firm’s partnership with AstraZeneca would be scaled back.
10 months ago
Last Updated: 2 months ago
The top analyst upgrades, downgrades and initiations seen on Tuesday included Alcoa, Broadcom, Dow, Lyft, Netflix, Roku, Walt Disney, Wingstop and Xilinx.
11 months ago
Last Updated: 2 months ago
The top analyst upgrades, downgrades and initiations seen on Monday included Amazon.com, CarMax, Celgene, Chevron, Exxon Mobil, Lyft, FedEx, Peabody Energy, UPS and Wells Fargo.
11 months ago
Last Updated: 2 months ago
Here are five top health care stocks that recently saw their 50-day moving average cross below the 200-day average, a death cross.
1 year ago
Last Updated: 2 months ago
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.
1 year ago
Last Updated: 2 months ago
The top analyst upgrades, downgrades and initiations seen on Friday included Avaya, AstraZeneca, HD Supply, HubSpot, Intel, Norfolk Southern, Ultimate Software and Valero Energy.
1 year ago
Last Updated: 2 months ago
The top analyst upgrades, downgrades and initiations seen on Friday included Activision Blizzard, BioMarin Pharmaceuticals, Ciena, Delta Air Lines, GlaxoSmithKline, Procter & Gamble, Regeneron...
1 year ago
Last Updated: 2 months ago
Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is not on the way very soon. Investors have been forced to see numerous waves of selling in...
1 year ago
Last Updated: 2 months ago
The include top analyst upgrades, downgrades and initiations seen from Thursday AVEO Pharmaceuticals, Boeing, Canopy Growth, Coty, Kimberly-Clark, Lululemon Athletica, Macy's, Sysco and Teladoc...
1 year ago
Last Updated: 2 months ago